| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/23/2001 | WO2001011060A3 Method of isolating secretion signals in lactic acid bacteria and novel secretion signals isolated from lactococcus lactis |
| 08/23/2001 | WO2001011025A3 Crystallization and structure determination of staphylococcus aureus thymidylate kinase |
| 08/23/2001 | WO2001010892A3 Peptide antagonists of factor VIIA |
| 08/23/2001 | WO2001010554A3 Laboratory robot and method and reagent kit for isolating nucleic acids |
| 08/23/2001 | WO2001009341A3 Method of determining the activity of 1-deoxy-d-xylulose-5-phosphate reductoisomerase and 1-deoxy-d-xylulose-5-phosphate synthase |
| 08/23/2001 | WO2001007611A3 Novel polynucleotides and method for the use thereof |
| 08/23/2001 | WO2001006016A3 Amplification of nucleic acids with electronic detection |
| 08/23/2001 | WO2000078954A3 Human transcriptional regulator proteins |
| 08/23/2001 | WO2000071742A3 An apparatus for the analysis of the electrophysiology of neuronal cells and its use in high-throughput functional genomics |
| 08/23/2001 | WO2000071668A3 Method for identifying components involved in signal transduction pathways in higher plants |
| 08/23/2001 | WO2000061795A3 Method for the amplification of HLA class I alleles |
| 08/23/2001 | WO2000058519A3 Charaterization of single nucleotide polymorphisms in coding regions of human genes |
| 08/23/2001 | WO2000006738A3 NUCLEIC ACIDS AND PROTEINS FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 08/23/2001 | WO1999064625A3 Methods and kits for discovery of rna-binding compounds |
| 08/23/2001 | WO1999047639A3 Staphylococcus aureus genes and polypeptides |
| 08/23/2001 | US20010016647 29 human secreted proteins |
| 08/23/2001 | US20010016575 Antisense modulation of human MDM2 expression |
| 08/23/2001 | US20010016361 System and method for programmable illumination pattern generation |
| 08/23/2001 | US20010016352 Oligonucleotides; detection cancer |
| 08/23/2001 | US20010016339 Pancreatic polypeptide |
| 08/23/2001 | US20010016338 DNA molecule encoding a variant alpha2B-adrenoceptor protein, and uses thereof |
| 08/23/2001 | US20010016336 Genetic engineered polypeptide |
| 08/23/2001 | US20010016334 Polypeptide; screening for bactericides |
| 08/23/2001 | US20010016332 Genetic engineering |
| 08/23/2001 | US20010016329 Methods and compositions for overcoming resistance to biologic and chemotherapy |
| 08/23/2001 | US20010016324 Enzymatic splitting |
| 08/23/2001 | US20010016323 Fluorescently labeled; resonance energy transferring |
| 08/23/2001 | US20010016319 Cloning of a novel G-protein coupled 7TM Receptor |
| 08/23/2001 | US20010016318 Methods for extrating similar expression patterns and related biopolymers |
| 08/23/2001 | US20010016317 Compound which precipitate or denaturing protein |
| 08/23/2001 | US20010016316 Spatially addressable, cleavable reflective signal elements, assay device and method |
| 08/23/2001 | US20010016315 Pit-1 gene polymorphism and trait selection in animals |
| 08/23/2001 | US20010016313 Quantitative analysis; measuring electrode potential |
| 08/23/2001 | US20010016312 Low temperature storage |
| 08/23/2001 | US20010016200 Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor |
| 08/23/2001 | US20010016194 Compounds that inhibit the binding of raf-1 or 14-3-3 proteins to the beta chain of il-2 receptor, and pharmaceutical compositions containing same |
| 08/23/2001 | EP1144681A3 Methods and kits for discovery of rna-binding compounds |
| 08/23/2001 | DE10016775A1 Elektrochemischer Sensor zur Bestimmung der Blutgerinnung, ein entsprechendes Blutgerinnungsmeßsystem sowie ein Verfahren zur Bestimmung der Blutgerinnung Electrochemical sensor for the determination of blood coagulation, a corresponding Blutgerinnungsmeßsystem and a method for determining blood coagulation |
| 08/23/2001 | DE10006767A1 Monitoring processing of sterile products, intended for invasive medical use, by measuring adenosine triphosphate (ATP) content or ATP-ase activity at all stages |
| 08/23/2001 | DE10006309A1 Verfahren zur Identifizierung von Substanzen, die die Aktivität von hyperpolarisationsaktivierten Kationen-kanälen modulieren A method for identifying substances that modulate the activity of hyperpolarization-activated cation channels, |
| 08/23/2001 | DE10005735A1 Withdrawing liquid stream containing suspended cells from liquid microsystem, comprises feeding stream at end of exit channel into decoupling stream to form discharge stream which is discharged through outlet |
| 08/23/2001 | DE10002820A1 Aminopeptidasen-Inhibitor Aminopeptidase inhibitor |
| 08/23/2001 | CA2435507A1 Improved assay for protein tyrosine phosphatases |
| 08/23/2001 | CA2400706A1 Genetically engineered skin cell types and toxicity assays |
| 08/23/2001 | CA2400588A1 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system |
| 08/23/2001 | CA2400473A1 Her-2 binding antagonists |
| 08/23/2001 | CA2400457A1 Parallel genotyping of multiple patient samples |
| 08/23/2001 | CA2400384A1 Methods and kits for proximity probing |
| 08/23/2001 | CA2400379A1 Microarray methods utilizing semiconductor nanocrystals |
| 08/23/2001 | CA2400360A1 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | CA2400342A1 Transgenic animal model for obesity expressing foxc2 |
| 08/23/2001 | CA2400332A1 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | CA2400328A1 Methods for identifying agents that cause a lethal phenotype, and agents thereof |
| 08/23/2001 | CA2400256A1 Compositions useful for regulating parkin gene activity |
| 08/23/2001 | CA2400207A1 Multiple-site reaction device and method |
| 08/23/2001 | CA2400136A1 Weight loss induced by reduction in neuropeptide y level |
| 08/23/2001 | CA2400101A1 Human protein tyrosine phosphatase, encoding dna and uses thereof |
| 08/23/2001 | CA2400034A1 Human kinases |
| 08/23/2001 | CA2400028A1 Libraries of optimum subsequence regions of mrna and genomic dna for control of gene expression |
| 08/23/2001 | CA2399163A1 Composite membranes for assaying biomolecules |
| 08/23/2001 | CA2398999A1 Compositions and methods for surface imprinting |
| 08/23/2001 | CA2398861A1 Gene disruption methodologies for drug target discovery |
| 08/23/2001 | CA2398825A1 Gtpase activating proteins |
| 08/23/2001 | CA2398628A1 5ht3 receptors of nematodes, polynucleotide molecules encoding same, andantagonists thereof |
| 08/23/2001 | CA2398603A1 Fibroblast growth factor-23 molecules and uses thereof |
| 08/23/2001 | CA2398482A1 Cell fusion assays using fluorescence resonance energy transfer |
| 08/23/2001 | CA2395473A1 Microcompetiton and human disease |
| 08/23/2001 | CA2395187A1 Molecular imprinting compositions and methods for binding and analyzing macromolecules |
| 08/23/2001 | CA2388738A1 Data analysis and display system for ligation-based dna sequencing |
| 08/22/2001 | EP1126278A2 Devices and methods for detection of an analyte based upon light interference |
| 08/22/2001 | EP1126272A1 Detection and/or quantification device of a precipitate upon the surface of a solid support |
| 08/22/2001 | EP1126035A1 Method for detecting gene affected by endocrine disruptor |
| 08/22/2001 | EP1126034A2 Coding sequences of the human BRCA1 gene |
| 08/22/2001 | EP1126033A2 Method for determining the effects of a growth-altering agent on a microbial colony |
| 08/22/2001 | EP1126032A1 Biosensor |
| 08/22/2001 | EP1126025A2 Oligonucleotide modulation of protein kinase C |
| 08/22/2001 | EP1125905A1 Segment synthesis |
| 08/22/2001 | EP1125128A1 Method for gold deposition |
| 08/22/2001 | EP1125127A2 Target analyte sensors utilizing microspheres |
| 08/22/2001 | EP1125120A1 Biological ion channels in nanofabricated detectors |
| 08/22/2001 | EP1125107A1 Tests for the rapid evaluation of ischemic states and kits |
| 08/22/2001 | EP1124993A2 Novel primers and probes for detecting hiv |
| 08/22/2001 | EP1124992A1 Methods for using co-regulated genesets to enhance detection and classification of gene expression patterns |
| 08/22/2001 | EP1124991A1 Phytomics: a genomic-based approach to herbal compositions |
| 08/22/2001 | EP1124990A1 Complexity management and analysis of genomic dna |
| 08/22/2001 | EP1124989A1 Method for determining cancer by determining expression of mage-10 |
| 08/22/2001 | EP1124988A1 Methods of identifying and characterizing mutations within bacterial dna gyrase and fabi |
| 08/22/2001 | EP1124987A2 Methods for screening protease variants for use in detergent compositions |
| 08/22/2001 | EP1124986A1 Nitrocoumarins for detecting all micro-organisms |
| 08/22/2001 | EP1124978A1 AN UNUSUAL RETROTRANSPOSON FROM THE YEAST $i(CANDIDA ALBICANS) |
| 08/22/2001 | EP1124971A1 Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use |
| 08/22/2001 | EP1124966A1 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 08/22/2001 | EP1124965A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 08/22/2001 | EP1124964A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 08/22/2001 | EP1124958A2 Corticosteroid synthesis-associated genes |
| 08/22/2001 | EP1124957A1 Pholasin |
| 08/22/2001 | EP1124953A2 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances |
| 08/22/2001 | EP1124951A2 Human sorting nexins |
| 08/22/2001 | EP1124949A1 Constructing and screening a dna library of interest in filamentous fungal cells |
| 08/22/2001 | EP1124948A1 Method for generating a gene library |